{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T08:57:43Z","timestamp":1725094663952},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.antiviral.2017.02.017","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T16:35:05Z","timestamp":1488386105000},"page":"174-178","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Co-administration of recombinant major envelope proteins (rA27L and rH3L) of buffalopox virus provides enhanced immunogenicity and protective efficacy in animal models"],"prefix":"10.1016","volume":"141","author":[{"given":"Amit","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Revanaiah","family":"Yogisharadhya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gnanavel","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerakyathappa","family":"Bhanuprakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awadh Bihari","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sathish Bhadravati","family":"Shivachandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.antiviral.2017.02.017_bib1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s13337-012-0110-3","article-title":"Prokaryotic expression and purification of highly soluble partial region of glycoprotein Erns of Indian strain of Classical Swine Fever virus","volume":"23","author":"Ahuja","year":"2012","journal-title":"Ind. J. Virol."},{"issue":"7","key":"10.1016\/j.antiviral.2017.02.017_bib2","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1128\/JVI.01854-07","article-title":"Vaccination of BALB\/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge","volume":"82","author":"Berhanu","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.02.017_bib3","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1586\/erv.12.116","article-title":"Animal poxvirus vaccines: a comprehensive review","author":"Bhanuprakash","year":"2012","journal-title":"Expert Rev. Vaccines"},{"issue":"7\u20138","key":"10.1016\/j.antiviral.2017.02.017_bib4","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1111\/j.1863-2378.2009.01314.x","article-title":"Zoonotic infections of buffalopox in India","volume":"57","author":"Bhanuprakash","year":"2010","journal-title":"Zoonoses Public Health"},{"issue":"40","key":"10.1016\/j.antiviral.2017.02.017_bib5","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1016\/j.vaccine.2010.07.030","article-title":"A\u00a0protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge","volume":"28","author":"Buchman","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.02.017_bib6","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1128\/JVI.72.2.1577-1585.1998","article-title":"A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate","volume":"72","author":"Chung","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.02.017_bib7","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1128\/JVI.80.5.2127-2140.2006","article-title":"Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles","volume":"80","author":"Chung","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.02.017_bib8","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1099\/0022-1317-71-10-2341","article-title":"Structural and functional analysis of Orthopox epitopes with neutralizing monoclonal antibodies","volume":"71","author":"Czerny","year":"1990","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2017.02.017_bib9","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1128\/JVI.79.18.11724-11733.2005","article-title":"Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice","volume":"7","author":"Davies","year":"2005","journal-title":"J.\u00a0Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2017.02.017_bib10","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/JVI.66.1.386-398.1992","article-title":"Identification and characterization of Vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans","volume":"66","author":"Demkowicz","year":"1992","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.02.017_bib11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/vr.102.17.382-a","article-title":"Susceptibility of infant white mice to buffalopox virus","volume":"102","author":"Dogra","year":"1978","journal-title":"Vet. Rec."},{"issue":"19","key":"10.1016\/j.antiviral.2017.02.017_bib12","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"Fogg","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.02.017_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.antiviral.2017.02.017_bib14","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.vaccine.2009.09.133","article-title":"Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates","volume":"28","author":"Hooper","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.02.017_bib15","first-page":"153","article-title":"Cellular and humoral immune responses to buffalopox virus in experimentally infected mice and rabbits","volume":"41","author":"Kaushik","year":"1980","journal-title":"Immunol"},{"key":"10.1016\/j.antiviral.2017.02.017_bib16","series-title":"Virus Taxonomy - Ninth Report of the International Committee on Taxonomy of Viruses","first-page":"291","author":"King","year":"2012"},{"issue":"41","key":"10.1016\/j.antiviral.2017.02.017_bib17","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1016\/j.vaccine.2015.08.058","article-title":"Structural analysis and immunogenicity of recombinant major envelope protein (rA27L) of buffalopox virus, a zoonotic Indian vaccinia-like virus","volume":"33","author":"Kumar","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.02.017_bib18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.antiviral.2015.12.004","article-title":"Immunogenicity and protective efficacy of recombinant major envelope protein (rH3L) of buffalopox virus in animal models","volume":"126","author":"Kumar","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.02.017_bib19","doi-asserted-by":"crossref","first-page":"22174","DOI":"10.1016\/S0021-9258(18)45686-4","article-title":"Structural and functional properties of the 14-kDa envelope protein of vaccinia virus synthesized in Escherichia coli","volume":"265","author":"Lai","year":"1990","journal-title":"J.\u00a0Biol. Chem."},{"issue":"10","key":"10.1016\/j.antiviral.2017.02.017_bib20","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1128\/JVI.65.10.5631-5635.1991","article-title":"The purified 14-kilodalton envelope protein of Vaccinia virus produced in Escherichia coli induces virus immunity in animals","volume":"65","author":"Lai","year":"1991","journal-title":"J.\u00a0Virol."},{"issue":"7","key":"10.1016\/j.antiviral.2017.02.017_bib21","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1128\/JVI.74.7.3353-3365.2000","article-title":"Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in\u00a0vitro and in\u00a0vivo","volume":"74","author":"Lin","year":"2000","journal-title":"J.\u00a0Virol."},{"issue":"5","key":"10.1016\/j.antiviral.2017.02.017_bib22","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.biologicals.2016.07.001","article-title":"Production of recombinant non-structural protein 3 hydrophobic domain deletion (NS3\u0394HD) protein of bluetongue virus from prokaryotic expression system as an efficient diagnostic reagent","volume":"44","author":"Mohanty","year":"2016","journal-title":"Biologicals"},{"key":"10.1016\/j.antiviral.2017.02.017_bib23","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1099\/0022-1317-83-5-1059","article-title":"Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditions","volume":"83","author":"Ramirez","year":"2002","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2017.02.017_bib24","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1128\/JVI.56.2.482-488.1985","article-title":"Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus","volume":"56","author":"Rodriguez","year":"1985","journal-title":"J.\u00a0Virol."},{"issue":"2","key":"10.1016\/j.antiviral.2017.02.017_bib25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virol.2006.07.017","article-title":"Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen","volume":"355","author":"Sakhatskyy","year":"2006","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.antiviral.2017.02.017_bib26","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.vaccine.2013.10.075","article-title":"Immunogenicity of highly conserved recombinant VacJ outer membrane lipoprotein of Pasteurella multocida","volume":"32","author":"Shivachandra","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.antiviral.2017.02.017_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rvsc.2014.11.013","article-title":"Recombinant transferrin binding protein A (TbpA) fragments of Pasteurella multocida serogroup B:2 provide variable protection following homologous challenge in mouse model","volume":"98","author":"Shivachandra","year":"2015","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.antiviral.2017.02.017_bib28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1017\/S1466252307001259","article-title":"Buffalopox: an emerging and re-emerging zoonosis","volume":"8","author":"Singh","year":"2007","journal-title":"Anim. Health Res. Rev."},{"key":"10.1016\/j.antiviral.2017.02.017_bib29","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s00705-006-0761-8","article-title":"Comparative sequence analysis of envelope protein genes of Indian bufflopox virus isolates","volume":"51","author":"Singh","year":"2006","journal-title":"Arch. Virol."},{"issue":"4","key":"10.1016\/j.antiviral.2017.02.017_bib30","first-page":"439","article-title":"Emerging and re-emerging zoonotic buffalopox infection: a severe outbreak in Kolhapur (Maharashtra), India","volume":"46","author":"Venkatesan","year":"2010","journal-title":"Vet. Ital."},{"key":"10.1016\/j.antiviral.2017.02.017_bib31","series-title":"Third Report of Joint FAO\/WHO Expert Committee on Zoonoses: Poxvirus Infection","first-page":"378","author":"WHO","year":"1967"},{"issue":"7","key":"10.1016\/j.antiviral.2017.02.017_bib32","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.vaccine.2006.10.009","article-title":"A\u00a0protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost","volume":"25","author":"Xiao","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.02.017_bib33","doi-asserted-by":"crossref","DOI":"10.1007\/s00705-016-3178-z","article-title":"Functional characterizations of recombinant major envelop protein (rB2L) of Orf virus","author":"Yogisharadhya","year":"2017","journal-title":"Arch. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216307902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216307902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:44:47Z","timestamp":1658709887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216307902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":33,"alternative-id":["S0166354216307902"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.02.017","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-administration of recombinant major envelope proteins (rA27L and rH3L) of buffalopox virus provides enhanced immunogenicity and protective efficacy in animal models","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}